Business

Innovating Diagnostics and What's Next

QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jonathan Siegrist, PhD, Executive Vice President of Research & Development and Chief Technology Officer at QuidelOrtho. Dr. Siegrist is a recognized leader in molecular diagnostics and biomedical engineering, driving innovation and next-generation diagnostic solutions.

articleQuidelortho CorporationDecember 18, 20254/company/quidel-corporation/news/innovating-diagnostics-and-whats-next
Innovating Diagnostics and What's Next

About this update from Quidelortho Corporation

[{"type":"text","content":"SAN DIEGO, Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jonathan Siegrist, PhD, Executive Vice President of Research & Development and Chief Technology Officer at QuidelOrtho. Dr. Siegrist is a recognized leader in molecular diagnostics and biomedical engineering, driving innovation and next-generation diagnostic solutions.","length":459,"tagName":"p"},{"type":"image","alt":"QuidelOrtho Science Bytes Episode 54","displaySize":"","headline":null,"caption":"QuidelOrtho Science Bytes Episode 54","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":210,"url":"https://media.zenfs.com/en/prnewswire.com/57bbc839e451a273080f236f86d85173"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7TsDpN5iVRKXpQjhhjfLkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM3MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/57bbc839e451a273080f236f86d85173","width":400,"height":210}},"href":"https://mma.prnewswire.com/media/2848324/QuidelOrtho_Science_Bytes_Episode_54.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Key insights include:","length":21,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Faster cardiac care: High-sensitivity troponin testing accelerates diagnosis and treatment for cardiac patients.","length":112,"tagName":"p"}]},{"val":[{"type":"text","content":"Non-invasive solutions: New assays enhance gastrointestinal health without invasive procedures.","length":95,"tagName":"p"}]},{"val":[{"type":"text","content":"Rapid response: Combo tests help clinicians manage respiratory surges efficiently.","length":82,"tagName":"p"}]},{"val":[{"type":"text","content":"Next-gen diagnostics: Advances in molecular platforms, informatics and AI enable smarter, more personalized care.","length":113,"tagName":"p"}]},{"val":[{"type":"text","content":"Innovation at scale: R&D strategies are shaping diagnostics to meet global healthcare challenges.","length":101,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":503,"olType":false},{"type":"text","content":"In the episode titled "2025 Diagnostic Trends and Innovations," Dr. Siegrist joins host Josh Casey to explore the transformative technologies redefining patient care. From hig...

More updates from Quidelortho Corporation

molecular diagnosticsJonathan Siegristpatient outcomesForward-Looking Statementsdiagnostic solutionsgastrointestinal healthQuidelOrthoQuidelOrtho Corporation